EXPLAINER

What is on the table at this week's ACIP meeting, and why the votes bind

The committee meets 18-19 September on COVID-19, hepatitis B and MMRV vaccines. RSV was dropped two days before. Adopted recommendations carry insurance and Vaccines for Children consequences.

The Advisory Committee on Immunization Practices meets on 18 and 19 September, and the Federal Register notices that set the agenda are worth reading closely — both for what they schedule and for what changed between the first notice and the second.

The original notice, published 29 August, listed four topics for discussion: COVID-19 vaccines; hepatitis B vaccine; measles, mumps, rubella and varicella (MMRV) vaccine; and respiratory syncytial virus [s1]. Recommendation votes and Vaccines for Children programme votes might be scheduled for all four [s1].

An amended notice published 16 September removed RSV [s2]. The agenda now reads: discussions on COVID-19 vaccines, hepatitis B vaccine, and MMRV vaccine, plus updates on ACIP workgroups, with recommendation votes and Vaccines for Children votes possibly scheduled for those three [s2]. The amendment also extended the first day, which now runs 10 a.m. to 5:30 p.m. EDT rather than 5 p.m., with the second day at 8:30 a.m. to 3 p.m. EDT [s2]. Agenda items remain subject to change [s2].

Why an advisory vote is not merely advisory

ACIP's formal role is to advise the CDC Director on the use of immunizing agents [s1]. In practice its recommendations carry two statutory consequences, both spelled out in the meeting notice itself.

The first is the Vaccines for Children programme. Under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review — and, as appropriate, revise — the list of vaccines for administration to vaccine-eligible children through VFC, along with schedules for dosing interval, dosage, and contraindications [s1]. VFC is the mechanism through which roughly half of American children receive federally purchased vaccines. A change to the VFC resolution changes what those children can get at no cost.

The second is private insurance. Under applicable provisions of the Affordable Care Act and section 2713 of the Public Health Service Act, ACIP immunization recommendations that have been adopted by the CDC Director and appear on CDC immunization schedules generally must be covered by applicable health plans [s1].

Two conditions in that sentence do real work. The recommendation must be adopted by the Director — an ACIP vote is not self-executing — and it must appear on CDC immunization schedules. A vote on 18 or 19 September is therefore the first step in a chain, not the end of one.

The three topics

COVID-19 vaccines. Both notices list COVID-19 vaccines for discussion with a possible recommendation vote and a possible VFC vote [s1][s2]. The notices do not describe what change, if any, is proposed.

Hepatitis B vaccine. Likewise listed for discussion with possible recommendation and VFC votes [s1][s2]. The hepatitis B birth dose has been part of the US childhood schedule for decades, and the VFC linkage means any change to the recommendation would flow through to what the programme purchases and covers.

MMRV vaccine. The combined measles-mumps-rubella-varicella product is listed the same way [s1][s2]. MMRV is distinct from separate MMR and varicella vaccines given at the same visit; a recommendation can differentiate between the combined and separate presentations without changing the underlying antigens a child receives.

Neither notice states what any workgroup will recommend, and neither previews a vote's direction. Anyone characterising the outcome before the meeting is speculating.

Public comment and access

Written comments had to be received between 2 and 13 September, identified by Docket No. CDC-2025-0454, submitted through regulations.gov or by mail [s1]. CDC does not accept comments by email [s1]. The original notice said time would be available for public comment at the meeting, and that the meeting was expected to be held at CDC with a virtual option [s1]. The amended notice describes the meeting as open to the public [s2]. The meeting is webcast live, with the link posted on the ACIP website [s1].

What to watch

Three things determine whether this week's meeting changes anything for patients.

Whether votes actually occur. Both notices use permissive language — votes "may be scheduled" [s1][s2] — and a vote can be tabled from the floor.

Whether the CDC Director adopts what passes. Adoption is a separate act, and the ACA coverage mandate in section 2713 attaches only after adoption and publication on the schedule [s1].

Whether the VFC resolutions move with the recommendations. VFC votes are taken separately, and the programme's coverage for children is governed by the resolution rather than by the clinical recommendation directly [s1].

Minutes and the meeting agenda are published on CDC's ACIP website [s1][s2].

This article is informational and is not medical advice.

Sources

Sources

  1. Meeting of the Advisory Committee on Immunization Practices (Notice)Centers for Disease Control and Prevention, Federal Register 90 FR 42245 , August 29, 2025
  2. Meeting of the Advisory Committee on Immunization Practices; Amended Notice of MeetingCenters for Disease Control and Prevention, Federal Register , September 16, 2025

More on

Related coverage